Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

NCT04061746 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Mesenchymal Stem Cells (MSCs)
OTHER: Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)

Sponsor

Medical University of South Carolina

Collaborators

[object Object]